Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea · Delayed Price · Currency is KRW 3,010.00
-90.00 (-2.90%)
At close: Feb 26, 2026
Milae Bioresources Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Other Revenue | - | - | - | - | - | 0 |
| 64,056 | 62,453 | 60,016 | 75,635 | 66,668 | 47,497 | |
Revenue Growth (YoY) | 0.96% | 4.06% | -20.65% | 13.45% | 40.36% | -5.16% |
Cost of Revenue | 54,514 | 54,554 | 51,911 | 66,210 | 58,308 | 40,821 |
Gross Profit | 9,542 | 7,900 | 8,105 | 9,425 | 8,361 | 6,676 |
Selling, General & Admin | 6,268 | 6,574 | 6,943 | 6,757 | 5,530 | 4,275 |
Research & Development | 550.26 | 545.24 | 534.89 | 521.61 | 461.83 | 504.36 |
Amortization of Goodwill & Intangibles | 350.33 | 114.02 | 153.7 | 183.97 | 170.86 | 43.22 |
Other Operating Expenses | 61.48 | 43.34 | 40.55 | 56.06 | 14.76 | 15.67 |
Operating Expenses | 8,218 | 7,716 | 8,084 | 7,842 | 6,506 | 5,517 |
Operating Income | 1,324 | 183.74 | 20.19 | 1,583 | 1,855 | 1,159 |
Interest Expense | -517.13 | -439.5 | -399.63 | -685.42 | -778.2 | -235.43 |
Interest & Investment Income | 392.45 | 731.35 | 1,008 | 366.78 | 116.75 | 135.58 |
Currency Exchange Gain (Loss) | 31.95 | -9.52 | -13.87 | -4.61 | 2.25 | -14.55 |
Other Non Operating Income (Expenses) | -26.17 | -114.25 | -12.44 | -63.6 | -16.15 | 41.12 |
EBT Excluding Unusual Items | 1,661 | 351.81 | 601.8 | 1,196 | 1,180 | 1,086 |
Gain (Loss) on Sale of Investments | - | - | 1.6 | -303.33 | -41.2 | -54.97 |
Gain (Loss) on Sale of Assets | 35.27 | 5.88 | 6.94 | 12.8 | 5.73 | 3.21 |
Asset Writedown | -875.01 | -875.01 | -356.45 | - | - | - |
Other Unusual Items | - | - | 139.06 | - | - | - |
Pretax Income | 821.41 | -517.31 | 392.95 | 905.4 | 1,144 | 1,034 |
Income Tax Expense | -176.52 | -97.58 | 33.74 | 27.25 | 65.28 | 81.11 |
Earnings From Continuing Operations | 997.93 | -419.73 | 359.21 | 878.15 | 1,079 | 953.2 |
Minority Interest in Earnings | -338.37 | -13.77 | 82.14 | 84.62 | 63.79 | -1.37 |
Net Income | 659.56 | -433.5 | 441.35 | 962.77 | 1,143 | 951.83 |
Net Income to Common | 659.56 | -433.5 | 441.35 | 962.77 | 1,143 | 951.83 |
Net Income Growth | 91.06% | - | -54.16% | -15.75% | 20.05% | -7.57% |
Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 18 | 18 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 18 | 18 |
Shares Change (YoY) | -0.63% | 1.34% | 2.90% | 5.51% | -0.06% | -0.13% |
EPS (Basic) | 33.94 | -22.24 | 22.94 | 51.50 | 64.49 | 53.68 |
EPS (Diluted) | 33.94 | -22.24 | 22.94 | 51.00 | 64.00 | 53.68 |
EPS Growth | 94.30% | - | -55.02% | -20.31% | 19.22% | -7.45% |
Free Cash Flow | 3,412 | -1,069 | 2,603 | 706.43 | 2,452 | 632.76 |
Free Cash Flow Per Share | 175.57 | -54.83 | 135.29 | 37.78 | 138.38 | 35.69 |
Gross Margin | 14.90% | 12.65% | 13.50% | 12.46% | 12.54% | 14.06% |
Operating Margin | 2.07% | 0.29% | 0.03% | 2.09% | 2.78% | 2.44% |
Profit Margin | 1.03% | -0.69% | 0.73% | 1.27% | 1.71% | 2.00% |
Free Cash Flow Margin | 5.33% | -1.71% | 4.34% | 0.93% | 3.68% | 1.33% |
EBITDA | 3,404 | 1,357 | 1,076 | 2,612 | 2,776 | 1,880 |
EBITDA Margin | 5.31% | 2.17% | 1.79% | 3.45% | 4.16% | 3.96% |
D&A For EBITDA | 2,080 | 1,173 | 1,056 | 1,029 | 920.77 | 720.23 |
EBIT | 1,324 | 183.74 | 20.19 | 1,583 | 1,855 | 1,159 |
EBIT Margin | 2.07% | 0.29% | 0.03% | 2.09% | 2.78% | 2.44% |
Effective Tax Rate | - | - | 8.59% | 3.01% | 5.71% | 7.84% |
Advertising Expenses | - | 331.9 | 515.17 | 418.44 | 106.4 | 8.68 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.